Corporate Events

Hamamatsu Photonics K.K., Board Meeting, Sep 25, 2026. Agenda: To consider and resolve to propose candidates for election as Directors at the 79th ordinary general meeting of shareholders of Hamamatsu Photonics K.K., to be held in mid-December 2026.

Hamamatsu Photonics K.K. announced the retirement of Kazuhiko Mori as Director and the planned appointments of Executive Officers at the meeting held on September 25, 2026.

Hamamatsu Photonics K.K. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the NanoZoomer S20MD and NanoZoomer S540MD Slide scanner systems. Building on the previously cleared NanoZoomer S360MD, these additions broaden the availability of FDA-cleared NanoZoomer systems in the United States, giving clinical pathology laboratories greater choice when selecting a NanoZoomer system that aligns with their operational requirements. With FDA-cleared systems spanning compact, routine, and high-throughput laboratory operations, Hamamatsu now offers a comprehensive NanoZoomer platform that provides a consistent user experience across the NanoZoomer product family. The FDA-cleared NanoZoomer portfolio now includes: NanoZoomer S20MD - Compact benchtop deployment; NanoZoomer S360MD - Routine laboratory workflows; NanoZoomer S540MD - High-throughput laboratory operations. Together, the NanoZoomer S20MD, S360MD, and S540MD Slide scanner systems provide pathology laboratories with a family of FDA-cleared solutions spanning compact benchtop, routine, and high-throughput laboratory operations.

Hamamatsu Photonics K.K. revised consolidated earnings guidance for the fiscal year ending September 30, 2026. For the year, the company expects net sales of JPY 239,000 million, operating profit of JPY 22,000 million, profit attributable to owners of parent of JPY 17,500 million and earnings per share of JPY 60.53.

The company closed its plan on July 31, 2026.

From July 1, 2026 to July 31, 2026, the company has repurchased 890,900 shares, representing 0.31% for ¥2,155.1 million. With this, the company has completed the repurchase of 10,627,700 shares, representing 3.6% for ¥19,999.62 million under the buyback announced on November 7, 2025.

Hamamatsu Photonics K.K., Q3 2026 Earnings Call, Aug 07, 2026

From April 1, 2026 to June 30, 2026, the company has repurchased 2,074,000 shares, representing 0.71% for ¥4,833.6 million. With this, the company has completed the repurchase of 9,736,800 shares, representing 3.29% for ¥17,844.52 million under the buyback announced on November 7, 2025.

Hamamatsu Photonics K.K. reported earnings results for the half year ended March 31, 2026. For the half year, the company reported sales was JPY 112,496 million compared to JPY 106,745 million a year ago. Net income was JPY 9,224 million compared to JPY 9,935 million a year ago. Basic earnings per share from continuing operations was JPY 31.3 compared to JPY 32.95 a year ago.

Hamamatsu Photonics K.K. announced that they will report Q3, 2026 results on Aug 06, 2026

Hamamatsu Photonics K.K. expected to report Q3 2026 results on August 6, 2026. This event was calculated by S&P Global (Created on May 15, 2026).

Hamamatsu Photonics K.K., ¥ 19.0, Cash Dividend, Sep-29-2026

Hamamatsu Photonics K.K. announced that they will report Q2, 2026 results on May 14, 2026

Hamamatsu Photonics K.K., Q2 2026 Earnings Call, May 15, 2026

From January 1, 2026 to March 31, 2026, the company has repurchased 2,743,800 shares, representing 0.93% for ¥5,011.04 million. With this, the company has completed the repurchase of 7,662,800 shares, representing 2.58% for ¥13,010.92 million under the buyback announced on November 7, 2025.

Sakura Finetek Global, a worldwide leader in automated tissue and slide preparation solutions for anatomic pathology, and Hamamatsu Photonics K.K., a global leader in imaging technologies, announced an alliance to enable consistent, scan-ready slides and clear digital images to support confident clinical decisions, with care for every patient. Together, both companies are focused on reducing variability and rework by aligning high-quality slide preparation with dependable digitization, so pathology teams can move efficiently from biopsy to diagnosis. The partnership is guided by a shared belief that engineering excellence ultimately serves one purpose: improve patient care. Sakura Finetek and Hamamatsu commit to collaborate with pathologists and laboratories to realize the benefits of one seamless workflow. Through this collaboration, Sakura Finetek and Hamamatsu plan to support laboratories with: Workflow alignment between slide preparation steps and digital scanning to help reduce rework, rescans, and delays; Joint customer engagement to help laboratories evaluate and design end-to-end workflows from histology through digital review; Shared educational resources highlighting best practices for scan-ready slide production and reliable whole slide imaging. Pathology is a chain, and every link matters. When slide preparation and imaging are engineered to work together, laboratories can move more confidently from specimen to insight. Hamamatsu Corporation and Sakura Finetek USA are introducing this partnership at USCAP 2026 in San Antonio, TX.

Laser Business Briefing

Hamamatsu Photonics K.K. provided consolidated earnings guidance for the fiscal year ending September 30, 2026. For the year, the company expects net sales of JPY 222,000 million, operating profit of JPY 17,200 million, profit attributable to owners of parent of JPY 14,300 million and earnings per share of JPY 48.67.

Hamamatsu Photonics K.K. reported earnings results for the first quarter ended December 31, 2025. For the first quarter, the company reported sales was JPY 51,910 million compared to JPY 50,587 million a year ago. Net income was JPY 2,784 million compared to JPY 4,188 million a year ago. Basic earnings per share from continuing operations was JPY 9.38 compared to JPY 13.76 a year ago.

Hamamatsu Photonics K.K. expected to report First-Half, 2026 results on May 8, 2026. This event was calculated by S&P Global (Created on January 23, 2026).

Hamamatsu Photonics K.K. reported earnings results for the fourth quarter and full year ended September 30, 2025. For the fourth quarter, the company reported sales was JPY 56,583 million compared to JPY 53,413 million a year ago. Net income was JPY 4,595 million compared to JPY 4,733 million a year ago. For the full year, sales was JPY 212,051 million compared to JPY 203,961 million a year ago. Net income was JPY 14,203 million compared to JPY 25,145 million a year ago. Basic earnings per share from continuing operations was JPY 47.32 compared to JPY 81.19 a year ago.

Hamamatsu Photonics K.K., ¥ 19.0, Cash Dividend, Mar-30-2026

Hamamatsu Photonics K.K., Q1 2026 Earnings Call, Feb 06, 2026

From November 7, 2025 to December 31, 2025, the company has repurchased 4,919,000 shares, representing 1.65% for ¥7,999.89 million. With this, the company has completed the repurchase of 4,919,000 shares, representing 1.65% for ¥7,999.89 million under the buyback announced on November 7, 2025.

Hamamatsu Photonics K.K., Board Meeting, Nov 08, 2025. Agenda: To consider the Status of Repurchase of Own Shares.

Hamamatsu Photonics K.K., Board Meeting, Dec 19, 2025. Agenda: To issue new shares.

Hamamatsu Photonics K.K. announced that they will report Q1, 2026 results on Feb 05, 2026

Hamamatsu Photonics K.K. provided consolidated earnings guidance for the fiscal year ending September 30, 2026. For the year, the company expects net sales of JPY 222,000 million, operating profit of JPY 17,200 million, profit attributable to owners of parent of JPY 14,300 million and earnings per share of JPY 47.86.

Hamamatsu Photonics K.K. proposed a cash dividend of ¥19 per share for the Fiscal year ended Sep. 30, 2025 against ¥19 per share a year ago. Scheduled date of Annual General Meeting of Shareholders: December 19, 2025. Scheduled date to begin dividend payments: December 22, 2025. The company provided dividend guidance for the second quarter of 2026 and full year ending Sep. 30, 2026. For the quarter, the company expects to pay a dividend of ¥19 per share against ¥19 per share a year ago. For the year, the company expects to pay a dividend of ¥19 per share against ¥19 per share a year ago.

Hamamatsu Photonics K.K. expected to report Q1 2026 results on February 6, 2026. This event was calculated by S&P Global (Created on November 11, 2025).

Hamamatsu Photonics K.K. (TSE:6965) announces a share repurchase program. Under the program, the company will repurchase up to 15,000,000 shares, representing 5.02% of its share capital, for ¥20,000 million. The company will repurchase its shares as part of its capital policy in response to changes in the business environment and as part of the company's comprehensive shareholder return policy. The share repurchase program will run until September 30, 2026.

The Board of Directors of Hamamatsu Photonics K.K. has authorized a buyback plan on November 7, 2025.

Hamamatsu Photonics K.K., Board Meeting, Nov 07, 2025. Agenda: To consider the announcement regarding Share Repurchase.

Hamamatsu Photonics K.K., Annual General Meeting, Dec 19, 2025.

Hamamatsu Photonics K.K., 2025 Earnings Call, Nov 10, 2025